NASDAQ
Entera Bio Ltd. (ENTX) has a free cash flow growth of -50.23% as of Friday, May 29, 2026. This represents a 266.21% decrease compared to its 12-month average of -13.72%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.